[Apolipoprotein A-I and high-density lipoprotein cholesterol in familial hyperlipoproteinemias]. 1986

K Raslová, and S Oravec, and P Kolesár, and M Lukácová

UI MeSH Term Description Entries
D006951 Hyperlipoproteinemias Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation. Hyperlipoproteinemia
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001054 Apolipoproteins A Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE. Apo-A,ApoA
D016632 Apolipoprotein A-I The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE. Apo A-I,Apo A-1,Apo A-I Isoproteins,Apo A1,Apo AI,ApoA-1,ApoA-I,Apolipoprotein A-1,Apolipoprotein A-I Isoprotein-2,Apolipoprotein A-I Isoprotein-4,Apolipoprotein A-I Isoproteins,Apolipoprotein A1,Apolipoprotein AI,Apolipoprotein AI Propeptide,Pro-Apo A-I,Pro-Apolipoprotein A-I,Proapolipoprotein AI,Apo A I Isoproteins,Apolipoprotein A 1,Apolipoprotein A I,Apolipoprotein A I Isoprotein 2,Apolipoprotein A I Isoprotein 4,Apolipoprotein A I Isoproteins,Pro Apo A I,Pro Apolipoprotein A I

Related Publications

K Raslová, and S Oravec, and P Kolesár, and M Lukácová
January 1983, Laboratornoe delo,
K Raslová, and S Oravec, and P Kolesár, and M Lukácová
February 2008, Journal of lipid research,
K Raslová, and S Oravec, and P Kolesár, and M Lukácová
June 1992, Arteriosclerosis and thrombosis : a journal of vascular biology,
K Raslová, and S Oravec, and P Kolesár, and M Lukácová
September 1991, Biochimie,
K Raslová, and S Oravec, and P Kolesár, and M Lukácová
January 2023, Clinica chimica acta; international journal of clinical chemistry,
K Raslová, and S Oravec, and P Kolesár, and M Lukácová
August 1999, Clinica chimica acta; international journal of clinical chemistry,
K Raslová, and S Oravec, and P Kolesár, and M Lukácová
January 2011, Journal of clinical lipidology,
K Raslová, and S Oravec, and P Kolesár, and M Lukácová
January 2024, Current opinion in cardiology,
K Raslová, and S Oravec, and P Kolesár, and M Lukácová
January 2009, Current atherosclerosis reports,
Copied contents to your clipboard!